- Abstract:
-
OBJECTIVES: To evaluate the discrimination, calibration, and net benefit performance of the Prostate Cancer Prevention Trial Risk Calculator (PCPTRC) across five European randomized study of screening for prostate cancer (ERSPC), 1 United Kingdom, 1 Austrian, and 3 US biopsy cohorts. METHODS: PCPTRC risks were calculated for 25,733 biopsies using prostate-specific antigen (PSA), digital rectal examination, family history, history of prior biopsy, and imputation for missing covariates. Predict...
Expand abstract - Publication status:
- Published
- Journal:
- World journal of urology
- Volume:
- 30
- Issue:
- 2
- Pages:
- 181-187
- Publication date:
- 2012-04-05
- DOI:
- EISSN:
-
1433-8726
- ISSN:
-
0724-4983
- URN:
-
uuid:a60de66b-a50f-4129-a85d-91bcd3fcd809
- Source identifiers:
-
365855
- Local pid:
- pubs:365855
- Copyright date:
- 2012
Journal article
Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record